P2X and P2Y Receptors-Role in the Pathophysiology of the Nervous System

被引:81
|
作者
Puchalowicz, Kamila [1 ]
Tarnowski, Maciej [2 ]
Baranowska-Bosiacka, Irena [1 ]
Chlubek, Dariusz [1 ]
Dziedziejko, Violetta [1 ]
机构
[1] Pomeranian Med Univ, Dept Biochem & Med Chem, PL-70111 Szczecin, Poland
[2] Pomeranian Med Univ, Dept Physiol, PL-70111 Szczecin, Poland
来源
关键词
Alzheimer's disease; ATP; depression; epilepsy; glioma; multiple sclerosis; neurodegenerative disease; neuropathic pain; P2X receptors; P2Y receptors; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; OLIGODENDROCYTE PROGENITOR MIGRATION; AMYLOID-BETA-PEPTIDE; GAIN-OF-FUNCTION; EXTRACELLULAR ATP; SPINAL MICROGLIA; NEUROPATHIC PAIN; NUCLEOTIDE RECEPTORS; PURINERGIC RECEPTOR; STATUS EPILEPTICUS;
D O I
10.3390/ijms151223672
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purinergic signalling plays a crucial role in proper functioning of the nervous system. Mechanisms depending on extracellular nucleotides and their P2 receptors also underlie a number of nervous system dysfunctions. This review aims to present the role of purinergic signalling, with particular focus devoted to role of P2 family receptors, in epilepsy, depression, neuropathic pain, nervous system neoplasms, such as glioma and neuroblastoma, neurodegenerative diseases like Parkinson's disease, Alzheimer's disease and multiple sclerosis. The above-mentioned conditions are associated with changes in expression of extracellular ectonucleotidases, P2X and P2Y receptors in neurons and glial cells, as well as releasing considerable amounts of nucleotides from activated or damaged nervous tissue cells into the extracellular space, which contributes to disturbance in purinergic signalling. The numerous studies indicate a potential possibility of using synthetic agonists/antagonists of P2 receptors in treatment of selected nervous system diseases. This is of particular significance, since numerous available agents reveal a low effectiveness and often produce side effects.
引用
收藏
页码:23672 / 23704
页数:33
相关论文
共 50 条
  • [21] Recommended tool compounds and drugs for blocking P2X and P2Y receptors
    Christa E. Müller
    Vigneshwaran Namasivayam
    Purinergic Signalling, 2021, 17 : 633 - 648
  • [22] Immunolocalisation of P2X and P2Y nucleotide receptors in the rat nasal mucosa
    Gayle, S
    Burnstock, G
    CELL AND TISSUE RESEARCH, 2005, 319 (01) : 27 - 36
  • [23] Differential regulation of renal ENaC by apical P2X and P2Y receptors
    Wildman, Scott Shaw Peppiatt
    Turner, Clare M.
    Marks, Joanne
    Shirley, David G.
    King, Brian F.
    Unwin, Robert J.
    FASEB JOURNAL, 2007, 21 (06): : A1328 - A1328
  • [24] Immunolocalisation of P2X and P2Y nucleotide receptors in the rat nasal mucosa
    Shimona Gayle
    Geoffrey Burnstock
    Cell and Tissue Research, 2005, 319 : 27 - 36
  • [25] Recommended tool compounds and drugs for blocking P2X and P2Y receptors
    Mueller, Christa E.
    Namasivayam, Vigneshwaran
    PURINERGIC SIGNALLING, 2021, 17 (4) : 633 - 648
  • [26] Expression of purinergic receptors (P2X, P2Y) in developing mammalian retina
    Ahmad, A
    McLeod, N
    Pece, K
    Zhou, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U635 - U635
  • [27] PURINOCEPTORS - ARE THERE FAMILIES OF P2X AND P2Y PURINOCEPTORS
    ABBRACCHIO, MP
    BURNSTOCK, G
    PHARMACOLOGY & THERAPEUTICS, 1994, 64 (03) : 445 - 475
  • [28] The P2Y/P2X divide: How it began
    Kennedy, Charles
    BIOCHEMICAL PHARMACOLOGY, 2021, 187
  • [29] Mechanisms involved in ventricular hypertrophy. Role of P2X, P2Y, and endothelin receptors.
    Cox, BF
    Clark, KL
    Welzel, GE
    Greenland, BD
    Roach, AG
    Valerio, MG
    Stankus, GP
    Perrone, MH
    FASEB JOURNAL, 1996, 10 (03): : 1784 - 1784
  • [30] Role of the purinergic P2X receptors in osteoclast pathophysiology
    Jorgensen, Niklas Rye
    CURRENT OPINION IN PHARMACOLOGY, 2019, 47 : 97 - 101